HCKT
The Hackett Group, Inc.
HCKT has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over HCKT overall, supported by stronger fundamentals and stronger modeled upside.
HCKT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Strong | |
| Stable | |
| Stable |
HCKT's profitability is currently strong, and its cash flow and balance sheet are stable, but its revenue is under pressure.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
HCKT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8.7x | $13.44 | — |
| Cheap | 16x | $11.45 | -15% |
| Current | 19x | $13.44 | — |
| Fair | 21x | $14.55 | +8.2% |
| Expensive | 39x | $26.96 | +101% |
Historical ranges are pointers, not guarantees.
HCKT's PE is in its fair range at 19x. If earnings grow as analysts expect, today's price would be 8.7x next year's earnings, in its cheap range.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over HCKT in the historical PE scenario, which offers more potential upside but is not a forecast.
HCKT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect HCKT's earnings to grow and its profitability to improve, with its revenue holding steady.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over HCKT on the outlook, with more favorable revenue expectations.
HCKT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.55 | +121% |
| Q3 2026 | $0.70 | +84% |
| Q2 2026 | $0.65 | +8.3% |
| Q1 2026 | $0.53 | -38% |
| Q4 2025 | $0.47 | -56% |
| Q3 2025 | $0.38 | -69% |
| Q2 2025 | $0.60 | -52% |
| Q1 2025 | $0.85 | -33% |
| Q4 2024 | $1.06 | -15% |
HCKT's earnings per share have fallen from their peak: $0.70 over the past year, against $1.47 in late 2022.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over HCKT in the latest year-over-year earnings comparison.
HCKT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $69.8M | -4.5% |
| Q2 2026 | $69.3M | -12% |
| Q1 2026 | $68.8M | -12% |
| Q4 2025 | $75.8M | -4.4% |
| Q3 2025 | $73.1M | -8.4% |
| Q2 2025 | $78.9M | +1.6% |
| Q1 2025 | $77.9M | +0.9% |
| Q4 2024 | $79.2M | +9.4% |
HCKT's revenue is shrinking: $70M last quarter, down 4.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +3.3 points |
| Q2 2026 | 11% | +5.3 points |
| Q1 2026 | 13% | +7.3 points |
| Q4 2025 | 12% | +2.2 points |
| Q3 2025 | 7.5% | -8.6 points |
| Q2 2025 | 5.8% | -10 points |
| Q1 2025 | 5.7% | -9.3 points |
| Q4 2024 | 9.8% | -6.1 points |
HCKT's operating margin was 11% last quarter, up 3.3 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over HCKT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over HCKT on profitability, with a higher operating margin.
HCKT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.3M | -115% |
| Q2 2026 | $12.6M | +237% |
| Q1 2026 | -$7.5M | -382% |
| Q4 2025 | $17.1M | -13% |
| Q3 2025 | $9M | -3.9% |
| Q2 2025 | $3.7M | -71% |
| Q1 2025 | $2.7M | +44% |
| Q4 2024 | $19.6M | -21% |
HCKT usually generates cash, though not every quarter: the latest was −$1M, but it generated $21M over the past year.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over HCKT on cash flow, with more consistent year-over-year improvement.
HCKT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -213K shares |
| 1 year | -9.6% | -2.7M shares |
| 3 years | -10% | -2.9M shares |
| 5 years | -24% | -7.9M shares |
| Available history | -23% | -7.5M shares |
HCKT has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.8M |
| Q2 2026 | $3.9M |
| Q1 2026 | $3M |
| Q4 2025 | $41.2M |
| Q3 2025 | $17.4M |
| Q2 2025 | $4.3M |
| Q1 2025 | $6.2M |
| Q4 2024 | $3.6M |
HCKT spent $50M buying back its own shares over the past year, up 58% from the year before.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
HCKT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.0x | Moderate |
| Q3 2025 | 1.1x | Healthy |
| Q2 2025 | 0.4x | Very low |
| Q1 2025 | 0.2x | Very low |
| Q4 2024 | -0.1x | Net Cash |
HCKT's net debt is about 1.9 years of its operating earnings (EBITDA), up from 1.1 years a year ago.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has the edge over HCKT on leverage, with a lower net debt burden relative to earnings.
HCKT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.5 | Neutral |
| Stochastic | 84.5 | Overbought |
HCKT's weekly RSI is 60 (neutral) and its Stochastic is 84 (overbought).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
HCKT PE vs Technology Sector
| Metric | HCKT | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 28x | 31% below |
| PE % | 38 | 35 | 3 pts above |
HCKT is trading at 19x earnings, a 31% discount to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over HCKT on valuation relative to its sector.
HCKT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.9 | 13% above |
| 20 week MA | $11.2 | 20% above |
| 50 week MA | $13.3 | 1% above |
| 100 week MA | $19.0 | 29% below |
| 200 week MA | $21.0 | 36% below |
HCKT has stronger trend alignment. HCKT is above 3 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
HCKT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.9 | $14.0 | -12% |
| 2021 | $14.0 | $20.7 | +47% |
| 2022 | $20.7 | $20.5 | -0.8% |
| 2023 | $20.5 | $22.8 | +11% |
| 2024 | $22.8 | $30.9 | +36% |
| 2025 | $30.9 | $20.0 | -35% |
| 2026 YTD | $20.0 | $13.4 | -33% |
HCKT has finished lower in three of the last six years. It's down 33% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over HCKT on returns for 2026, with the stronger performance.